艾意凯：2024年范围三排放：制药公司的战略要务报告（英文版）

Net-zero emissions initiatives have gained traction in recent years, particularly in the pharmaceutical industry. Pharma has traditionally lagged other industries in emissions commitments, but market pressures from customers (e.g., health systems) and regulators have contributed to shifting emissions targets into focus. Thirteen of the top 20 pharma companies by revenue have committed to net-zero, and among these, over half made their commitments in the past three years (see Figure 3 below).<